Tim-3 expression in renal cell carcinoma is associated with longer progression-free survival and OS (51), whereas low Tim-3 expression levels in tumor tissue is associated with poor prognosis in metastatic prostate cancer (52). The gene discussed is HAVCR2; the disease is renal cell carcinoma.